NCT04829643View on ClinicalTrials.gov

Axillary Staging in Early Breast Cancer: SNB vs PET/MRI

NACompletedINTERVENTIONAL

Enrollment

246

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions

Breast CancerSentinel Lymph NodeEarly-stage Breast Cancer

Interventions

DIAGNOSTIC_TEST

PET/MRI

A consecutive cohort of 247 patients with early BC and no suspicious nodes at both clinical and A-US evaluations and candidates to upfront surgery and SNB will be recruited

Trial Locations (1)

20132

Oreste Davide Gentilini, Milan

All Listed Sponsors

collaborator

IBFM- Consiglio Nazionale delle Ricerche

UNKNOWN

lead

IRCCS San Raffaele

OTHER

NCT04829643 - Axillary Staging in Early Breast Cancer: SNB vs PET/MRI | Biotech Hunter | Biotech Hunter